PP
TSVT

PFS Partners’s 2seventy bio TSVT Stock Holding History

PFS Partners’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-113
Closed -$559 – 518
2025
Q1 		$559 Hold
113
– – ﹤0.01% 417
2024
Q4 		$333 Hold
113
– – ﹤0.01% 430
2024
Q3 		$534 Hold
113
– – ﹤0.01% 425
2024
Q2 		$436 Hold
113
– – ﹤0.01% 415
2024
Q1 		$605 Hold
113
– – ﹤0.01% 436
2023
Q4 		$483 Hold
113
– – ﹤0.01% 432
2023
Q3 		$443 Hold
113
– – ﹤0.01% 441
2023
Q2 		$1.14K Hold
113
– – ﹤0.01% 442
2023
Q1 		$1.15K Hold
113
– – ﹤0.01% 354
2022
Q4 		$1.06K Buy
+113
New +$1.59K ﹤0.01% 343

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PFS Partners's TSVT Position: Q2 2025 in Review

PFS Partners sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 113 shares — an estimated $559 sold.

PFS Partners first reported a position in TSVT in Q4 2022 and held it in 10 quarters. The position peaked at $1.15K in Q1 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • PFS Partners reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • PFS Partners sold 113 2seventy bio shares in Q2 2025, an estimated $559.
  • PFS Partners first reported a position in 2seventy bio in Q4 2022 and held it in 10 quarters.
  • PFS Partners's 2seventy bio position peaked at $1.15K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on PFS Partners's 13F filing for Q2 2025, filed 16 Jul 2025.